EpiPharm AG is a clinical-stage biotechnology company developing topical treatments and dermato-cosmetic products based on multi-active, plant-derived compositions that include artemisinin derivatives. Its projects address skin disorders such as seborrhoeic keratosis and pigmented lesions, and the company offers co-development and licensing opportunities for its pipeline.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered4
Dermato-cosmetic products
Natural, multi-active dermato-cosmetic products against various skin conditions; including Epi MA Serum, Epi MA-T Creme, Epi DA Serum and Epi SP Creme.
Pharmaceutical projects
Pharmaceutical projects for the treatment of seborrhoeic keratosis and pigmented skin lesions; includes EPI-SK14, EPI-SK17 and EPI-N06 in development or in clinical testing.
Solution for skin disorders
Innovative, natural products for various skin conditions; focus on plant-based active ingredients, synergistic formulations, and high quality and sustainability standards.
Co-development and licensing
Co-development and licensing of pipeline projects for various skin conditions; contacts for partnerships and interest in licensing are explicitly offered.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.